Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Indaptus Therapeutics, Inc. - Common Stock
(NQ:
INDP
)
3.130
+0.130 (+4.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Indaptus Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 29, 2021
Gainers Cumberland (NASDAQ:CPIX) share...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 29, 2021
Gainers Krystal Biotech (NASDAQ:
Via
Benzinga
Maxim Upgrades Indaptus Therapeutics To Buy
↗
October 19, 2021
Maxim analyst has upgraded Indaptus Therapeutics Inc (NASDAQ: INDP) to Buy from Hold with a $16 price target, an upside of over 100%. Analyst Jason McCarthy says,...
Via
Benzinga
48 Biggest Movers From Yesterday
↗
September 21, 2021
Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...
Via
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
↗
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
↗
October 19, 2021
Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 20, 2021
Gainers Atea Pharmaceuticals (NASDAQ:AVIR) shares increased by 13.83% to $29.86 during Monday's regular session. Trading volume for this security as of 12:30 EST is 3....
Via
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
↗
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
↗
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
↗
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
↗
September 20, 2021
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 17, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 16, 2021
Gainers Stealth BioTherapeutics (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
↗
September 16, 2021
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio...
Via
Benzinga
53 Biggest Movers From Yesterday
↗
September 16, 2021
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...
Via
Benzinga
Topics
Initial Public Offering
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 15, 2021
Gainers Larimar Therapeutics (NASDAQ:
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; GreenSky Shares Spike Higher
↗
September 15, 2021
Toward the end of trading Wednesday, the Dow traded up 0.72% to 34,827.73 while the NASDAQ rose 0.58% to 15,125.38. The S&P also rose, gaining 0.82% to 4,479.33. The U.S. has...
Via
Benzinga
Topics
Stocks
INDP Stock: The Patent News That Has Indaptus Therapeutics Skyrocketing Today
↗
September 15, 2021
Shares of INDP stock are skyrocketing on Wednesday after the U.S. Patent and Trademark Office made a big move for Indaptus Therapeutics.
Via
InvestorPlace
Topics
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares...
Via
Benzinga
Mid-Day Market Update: Crude Oil Surges 3%; Kaival Brands Shares Plunge
↗
September 15, 2021
Midway through trading Wednesday, the Dow traded up 0.16% to 34,633.63 while the NASDAQ fell 0.02% to 15,035.07. The S&P also rose, gaining 0.19% to 4,451.27. The U.S. has the...
Via
Benzinga
Topics
Stocks
38 Stocks Moving In Wednesday's Mid-Day Session
↗
September 15, 2021
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of...
Via
Benzinga
Topics
Intellectual Property
Why Are Indaptus Therapeutics Shares Shooting Higher On Wednesday?
↗
September 15, 2021
The United States Patent and Trademark Office has issued a notice of patent allowance to Indaptus Therapeutics Inc's (NASDAQ: INDP) platform technology....
Via
Benzinga
Topics
Intellectual Property
Mid-Morning Market Update: Markets Mixed; Industrial Production Rises 0.4% In August
↗
September 15, 2021
Following the market opening Wednesday, the Dow traded up 0.13% to 34,621.78 while the NASDAQ fell 0.25% to 14,999.72. The S&P also rose, gaining 0.03% to 4,444.41. The U.S....
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
↗
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
↗
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
↗
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
99 Biggest Movers From Yesterday
↗
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit